Lynn E. Bayless
General Counsel at MUSTANG BIO, INC.
Network origin in Lynn E. Bayless first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 21 | |
| Public Company | Pharmaceuticals: Major | 20 | |
| Subsidiary | Pharmaceuticals: Major | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lynn E. Bayless via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Compliance Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Investor Relations Contact | |
| CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Investor Relations Contact | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Graduate Degree | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| AKOUOS | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| TERNS PHARMACEUTICALS, INC. | Biotechnology | Chairman Chief Executive Officer Chief Operating Officer | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member | |
| JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact Corporate Officer/Principal | |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| Weill Cornell Medical College | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Comptroller/Controller/Auditor | |
Silver Acquisition Co. Ltd.
 Silver Acquisition Co. Ltd. BiotechnologyHealth Technology Founded in 2014, Silver Acquisition Co. Ltd. is a biotechnology research and British experimental development company. Part of Biogen, Inc., the company is based in Maidenhead, UK. The company's focus is on developing new biotechnology products through research and experimentation. | Biotechnology | Director/Board Member Director/Board Member | |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Old Convergence Pharmaceuticals Ltd.
 Old Convergence Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2010, Old Convergence Pharmaceuticals Ltd. is a subsidiary of Biogen, Inc. that develops analgesics for the treatment of chronic pain. The company is based in Maidenhead, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree | |
Convergence Pharmaceuticals Holdings Ltd.
 Convergence Pharmaceuticals Holdings Ltd. Financial ConglomeratesFinance Part of Biogen, Inc., Convergence Pharmaceuticals Holdings Ltd. functions as an investment holding British company. The company is based in Maidenhead, UK. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Syracuse University | College/University | Undergraduate Degree Undergraduate Degree | |
| CYCLERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| FOUNDATION MEDICINE INC | Medical/Nursing Services | General Counsel Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
| Amherst College | College/University | Graduate Degree Undergraduate Degree | |
| Bentley University | College/University | Graduate Degree Undergraduate Degree | |
| Tuck School of Business at Dartmouth | College/University | Masters Business Admin Masters Business Admin | |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member Chairman | |
| University of Vermont | College/University | Undergraduate Degree Undergraduate Degree | |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
| EPIZYME, INC. | Biotechnology | Chairman General Counsel | |
Cydan LLC
 Cydan LLC Medical DistributorsDistribution Services Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA. | Medical Distributors | Chairman Founder | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
Edimer Pharmaceuticals, Inc.
 Edimer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edimer Pharmaceuticals, Inc. provides biopharmaceutical products for improving the health and quality of life of families living with XLHED. It has developed EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), which is a rare orphan disease that causes symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company was founded by Pascal Schneider and Olivier Gaide in 2009 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Founder | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder |
Statistics
International
| United States | 40 |
| United Kingdom | 10 |
| Ireland | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 12 |
| Finance | 4 |
| Health Services | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 221 |
| Corporate Officer/Principal | 124 |
| Independent Dir/Board Member | 83 |
| Chairman | 62 |
| Director of Finance/CFO | 52 |
Most connected contacts
| Insiders | |
|---|---|
| David Mott | 45 |
| Perry Karsen | 38 |
| Wendy Dixon | 25 |
| Michael Weiss | 25 |
| Jane Henderson | 24 |
| Lindsay Rosenwald | 23 |
| Neil Herskowitz | 22 |
| Steven Hyman | 21 |
| Michael Higgins | 20 |
| Chris Hollowood | 19 |
| David Lubner | 19 |
| Scott Whitcup | 18 |
| Glenn F. Pierce | 17 |
| J. Goater | 17 |
| David Fellows | 16 |
- Stock Market
- Insiders
- Lynn E. Bayless
- Company connections
